Get started
Author

Kaofei Sayion

Observed names: KAOFEI SAYION, Sayion, Kaofei
ORCID: 0009-0006-2270-9370
Observed ORCID: 0009-0006-2270-9370
OpenAlex ID: A5141126546
Cholinesterase inhibitors and sexual disinhibition in dementia: a FAERS disproportionality study
2026 · Kaofei Sayion · Naunyn-Schmiedeberg s Archives of Pharmacology · 2
Stricter product definitions and sex-stratified sensitivity analyses for a CAERS disproportionality study of sexual-enhancement supplements (peer-review revision analyses, Andrology manuscript 4918131)
2026 · KAOFEI SAYION · Open Science Framework
Regular dietary supplement use and subsequent sexual activity: a prospective analysis of the Midlife in the United States study
2026 · KAOFEI SAYION · Open Science Framework
Nicotine-only, THC-only, and dual vaping are not exchangeable: how exposure composition determines the pooled "vaping"-anxiety association (2024 NSDUH)
2026 · KAOFEI SAYION · Research Square
Analysis code for: Cholinesterase inhibitors and sexual disinhibition in dementia — a FAERS disproportionality study
2026 · Sayion, Kaofei · Zenodo (CERN European Organization for Nuclear Research)
Sexual-enhancement supplements in CAERS: disproportionality analysis code and derived tables
2026 · Sayion, Kaofei · Zenodo (CERN European Organization for Nuclear Research)
Palikatay: Maintainable New-Word Injection for Machine Translation into Sakizaya, a Critically Endangered Formosan Language
2026 · Sayion, Kaofei · Zenodo (CERN European Organization for Nuclear Research)
Past-Month Nicotine versus THC E-Cigarette Use and Moderate-to-Severe Anxiety Symptoms Among U.S. Adults: A Cross-Sectional Analysis of the 2024 National Survey on Drug Use and Health
2026 · KAOFEI SAYION · Research Square
PDF
Analysis code for: Cholinesterase inhibitors and sexual disinhibition in dementia — a FAERS disproportionality study
2026 · Sayion, Kaofei · Zenodo (CERN European Organization for Nuclear Research)
Works count: 9
Citation count: 2
H-index: 1
I10-index:
Year
Topic
Type